Cargando…

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management

BACKGROUND: After each cycle of [(177)Lu]-DOTA-TATE peptide receptor radionuclide therapy (PRRT) dosimetry is performed to enable precise calculation of the radiation-absorbed dose to tumors and normal organs. Absorbed doses are routinely calculated from three quantitative single-photon emission com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chicheportiche, Alexandre, Ben-Haim, Simona, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Meirovitz, Amichay, Gross, David J., Godefroy, Jeremy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977807/ https://www.ncbi.nlm.nih.gov/pubmed/31975156 http://dx.doi.org/10.1186/s40658-020-0273-8

Ejemplares similares

Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)
por: Chicheportiche, Alexandre, et al.
Publicado: (2018)

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in (68)Ga-DOTATATE PET/CT studies?
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

Predictive power of the post-treatment scans after the initial or first two courses of [(177)Lu]-DOTA-TATE
por: Chicheportiche, Alexandre, et al.
Publicado: (2018)

Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
por: Arnon, Johnathan, et al.
Publicado: (2022)

The Autophagy Inhibitor Chloroquine, Alone or in Combination with mTOR Inhibitors, Displays Anti-Tumor Effects in In Vitro and In Vivo Lung Carcinoid Models
por: Knigin, Adi, et al.
Publicado: (2021)

Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021)

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
por: Twito, Orit, et al.
Publicado: (2023)

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients
por: Theiler, Deborah, et al.
Publicado: (2021)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)

Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease
por: Nahmias, Avital, et al.
Publicado: (2015)

Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016)

Comparison of different calculation techniques for absorbed dose assessment in patient specific peptide receptor radionuclide therapy
por: Finocchiaro, Domenico, et al.
Publicado: (2020)

Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?
por: Bar-Moshe, Yehonatan, et al.
Publicado: (2017)

Feasibility of simplifying renal dosimetry in (177)Lu peptide receptor radionuclide therapy
por: Sundlöv, Anna, et al.
Publicado: (2018)

Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
por: Orevi, Marina, et al.
Publicado: (2022)

The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN
por: Alexandraki, Krystallenia I., et al.
Publicado: (2020)

Simplified dosimetry for kidneys and tumors in (177)Lu-labeled peptide receptor radionuclide therapy
por: Ardenfors, Oscar, et al.
Publicado: (2022)

Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
por: Walrand, Stephan, et al.
Publicado: (2021)

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
por: Brans, B., et al.
Publicado: (2007)

Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
por: Ljungberg, Michael, et al.
Publicado: (2015)

Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATOC: A Pilot Study
por: Prasad, Vikas, et al.
Publicado: (2021)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose
por: Brosch-Lenz, Julia, et al.
Publicado: (2023)

Software-assisted dosimetry in peptide receptor radionuclide therapy with (177)Lutetium-DOTATATE for various imaging scenarios
por: Kupitz, Dennis, et al.
Publicado: (2017)

Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review
por: Huizing, Daphne Merel Valerie, et al.
Publicado: (2018)

Radiation protection dosimetry: radionuclides and radiation protection data handbook
por: Nucl. Techn. Publ.
Publicado: (2002)

Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review
por: Li, Tiantian, et al.
Publicado: (2017)

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
por: Ljungberg, Michael, et al.
Publicado: (2016)

Towards accurate (177)Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio
por: Raskin, Stanislav, et al.
Publicado: (2023)

Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Forrer, Flavio, et al.
Publicado: (2009)

Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
por: Marquis, H., et al.
Publicado: (2021)

An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry
por: Kovan, Bilal, et al.
Publicado: (2023)

Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning
por: Sapienza, Marcelo Tatit, et al.
Publicado: (2019)

Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates
por: Marquis, H, et al.
Publicado: (2023)

Adsorption of radionuclides on ferrocyanides: quantum-chemical calculations
por: Stasyuk, I V, et al.
Publicado: (2006)

(99m)Tc MIBI Scintigraphy for Classification of Amiodarone-induced Thyrotoxicosis
por: Itzkovich, Dror, et al.
Publicado: (2022)

A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy
por: Huizing, Daphne M. V., et al.
Publicado: (2020)

A Rare Case of Cutaneous Metastasis of Bladder Transitional Cell Carcinoma
por: Fachler, Tahel, et al.
Publicado: (2021)

Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression
por: Jahn, Ulrika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_smrrvmkilrj3crmhmborvjatd1